Idiopathic pulmonary arterial hypertension in a young patient with the cohen syndrome

Hellenic Journal of Cardiology

Volumn 54, Issue 2, 2013, Pages 143-146

  Cokkinos, Philip ^a   Gkouziouta, Aggeliki ^a   Karavolias, George ^a   Kariofillis, Panagiotis ^a   Voudris, Vassilis ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Cohen syndrome; Pulmonary hypertension

Indexed keywords

ANTIBIOTIC AGENT; BOSENTAN; COUMARIN DERIVATIVE; FUROSEMIDE; OSELTAMIVIR; PROSTACYCLIN; SILDENAFIL; VALPROIC ACID;

ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CENTRAL VENOUS CATHETERIZATION; COHEN SYNDROME; DEATH; DYSPNEA; ELECTROCARDIOGRAPHY; EPILEPSY; FAINTNESS; FOLLOW UP; HEART ARREST; HEART CATHETERIZATION; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; INFLUENZA VIRUS A H1N1; KLEBSIELLA PNEUMONIAE INFECTION; LIVER FUNCTION TEST; LUNG ARTERY PRESSURE; MALE; MULTIPLE ORGAN FAILURE; PNEUMOTHORAX; PULMONARY HYPERTENSION; SUPERINFECTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION;

ADOLESCENT; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; DEVELOPMENTAL DISABILITIES; FATAL OUTCOME; FINGERS; HUMANS; HYPERTENSION, PULMONARY; INTELLECTUAL DISABILITY; MALE; MICROCEPHALY; MUSCLE HYPOTONIA; MYOPIA; OBESITY; PIPERAZINES; PURINES; SULFONAMIDES; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84878168444     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kivitie-Kallio S, Norio R. Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet. 2001; 102: 125-135.
2. Tahvanainen E, Norio R, Karila E, et al. Cohen syndrome gene assigned to the long arm of chromosome 8 by linkage analysis. Nat Genet. 1994; 7: 201-204.
3. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009; 30: 2493-2537.
4. Humbert M, Barst RJ, Robbins IM, et al. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur Respir J. 2004; 24: 353-359.
5. Higgins AD, Shaw CJ, Johnson JG, et al. Monoclonal antibody kit for identification of the novel 2009 H1N1 influenza A virus. J Clin Microbiol. 2010; 48: 2677-2682.
6. Smith SM, Gums JG. Antivirals for influenza: strategies for use in pediatrics. Pediatr Drugs. 2010; 12: 285-299.
7. Cohen MM Jr, Hall BD, Smith DW, Graham CB, Lampert KJ. A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies. J Pediatr. 1973; 83: 280-284.
8. Hurmerinta K, Pirinen S, Kovero O, Kivitie-Kallio S. Cranio-facial features in Cohen syndrome: an anthropometric and cephalometric analysis of 14 patients. Clin Genet. 2002; 62: 157-164.
9. Thomaidis L, Fryssira H, Katsarou E, Metaxotou C. Cohen syndrome: two new cases in siblings. Eur J Pediatr. 1999; 158: 838-841.
10. Olivieri O, Lombardi S, Russo C, Corrocher R. Increased neutrophil adhesive capability in Cohen syndrome, an auto-somal recessive disorder associated with granulocytopenia. Haematologica. 1998; 83: 778-782.
11. Douzgou S, Petersen MB. Clinical variability of genetic isolates of Cohen syndrome. Clin Genet. 2011; 79: 501-506.
12. Kivitie-Kallio S, Eronen M, Lipsanen-Nyman M, Marttinen E, Norio R. Cohen syndrome: evaluation of its cardiac, endocrine and radiological features. Clin Genet. 1999; 56: 41-50.
13. Sack J, Friedman E. Cardiac involvement in the Cohen syndrome: a case report. Clin Genet. 1980; 17: 317-319.
14. Schlichtemeier TL, Tomlinson GE, Kamen BA, Waber LJ, Wilson GN. Multiple coagulation defects and the Cohen syndrome. Clin Genet. 1994; 45: 212-216.
15. Mehta Y, Schou H. The anaesthetic management of an infant with frontometaphyseal dysplasia (Gorlin-Cohen syndrome). Acta Anaesthesiol Scand. 1988; 32: 505-507.
16. Valerio CJ, Coghlan JG. Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient. Vasc Health Risk Manag. 2009; 5: 607-619.
17. Parcharidis G. Pulmonary hypertension. Hellenic J Cardiol. 2011; 52: 381.